|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Removal of organo phosphorus pesticides from water by electrogenerated Fentonrs rea gent 显示文摘 | Guivarch E Oturan N Oturan M A | 2003 | Environmental Chemistry Letters2003，1，3： | 1 |
| 2 | Degradation of azo dyes in water by electro-Fcnton process显示文摘 | GUIVARCH E TREVIN S LAHITTE C | 2003 | Enviro Chem Lett2003，1，： | 1 |
| 3 | Phar- maeodynamics and pharmacokineties of propofol in a medium-chain triglyceride emulsion 显示文摘 | Ward DS Norton RJ Guivarch PH | 2002 | Anesthesi- ology2002，97，6： | 1 |
| 4 | Markers of in- testinal injury are associated with endotoxemia in suc- cessfully resuscitated patients显示文摘 | Grimaldi D Guivarch E Neveux N | 2013 | Resuscitation2013，84，1： | 1 |
| 5 | Removal of organophosphorus pesticides from water by electrogenerated Fenton’s reagent显示文摘 | Elodie Guivarch Nihal Oturan Mehmet A. Oturan | 2003 | Environmental Chemistry Letters2003，，3： | 1 |
| 6 | The resilience of the Indian economy to rising oil prices as a validation test for a global energy–environment–economy CGE model显示文摘 | Céline Guivarch Stéphane Hallegatte Renaud Crassous | 2009 | Energy Policy2009，，11： | 1 |
| 7 | Removal of organophosphorus pesticides from water by electrogonerated Fenton's reagent 显示文摘 | Guivarch E Oturan N | 2003 | Envrionmental Chemistry Letters2003，，1： | 1 |
| 8 | 2℃ or Not 2℃ 显示文摘 | Guivarch C Hallegatte S | 2013 | Global Environmental Change2013，23，1： | 1 |
| 9 | Sectoral targets for developing countries:Combining“Common but differentiated responsibilities”with“Meaningful participation”显示文摘 | Hamdi-Cherif M Guivarch C Quirion P | 2010 | Climate Policy2010，11，1： | 1 |
| 10 | Pharmacodynamics and pharmacokinetics of propofol in a mediumchain triglyceride emulsion 显示文摘 | Ward DS Norton JR Guivarch PH | 2002 | Anesthesiology2002，97，6： | 1 |
| 11 | Building SSPs for climate policy analysis: a scenario elicitation methodology to map the space of possible future challenges to mitigation and adaptation显示文摘 | Julie Rozenberg Céline Guivarch Robert Lempert Stéphane Hallegatte | 2014 | Climatic Change2014，，3： | 1 |
| 12 | Degradation of azo dyes in water by Electro-Fenton process显示文摘 | Guivarch E Trevin S | 2003 | Environ Chem Lett2003，，1： | 1 |
| 13 | Differential subcellular distribution and transcriptional activity of ΣE3,ΣE4,and ΣE3-4 isoforms of the rat estrogen receptor-α显示文摘 | Catherine Pasqualini Dominique Guivarch Jean-Vianney Barnier | 2001 | Mol Endocrinol2001，15，6： | 1 |
| 14 | Induction of male sterility implants by metabolic engineering of the carbohydrate supply显示文摘 | GOETZ M GODT D E GUIVARCH A | 2001 | Proc Natl Acad Sci USA2001，98，： | 1 |
| 15 | Markers of intestinalinjury are associated with endotoxemia in successfully resuscitatedpatients显示文摘 | Grimaldi D Guivarch E Neveux N | 2013 | Resuscitation2013，84，1： | 1 |
| 16 | The resilience of the Indian economy to rising oil prices as a validation test for a global energy environment economy CGE model显示文摘 | Guivarch C Hallegatte S Crassousa R | | 0，，11： | 1 |
| 17 | Markers of intestinal injury are associated with endotoxemia in successfully resuscitated patients显示文摘 | Grimaldi D Guivarch E Neveux N | 2013 | Resuscitation2013，84，1： | 1 |
| 18 | Removal of organophosphorus pesticides from water by electrogenerated Fenton’s reagent显示文摘 | Elodie Guivarch Nihal Oturan Mehmet A. Oturan | 2003 | Environmental Chemistry Letters2003，，3： | 1 |
| 19 | Degradation of azo dyes in water by Electro-Fenton process显示文摘 | Elodie Guivarch Stephane Trevin Claude Lahitte Mehmet A. Oturan | 2003 | Environmental Chemistry Letters2003，，1： | 1 |
| 20 | Telaprevir- and boceprevir-based tritherapies in real practice for F3-F4 pretreated hepatitis C virus patients显示文摘AIM:To assess,in a routine practice setting,the sus-tained virologic response(SVR) to telaprevir(TPV) or boceprevir(BOC) in hepatitis C virus(HCV) nullresponders or relapsers with severe liver fibrosis.METHODS:One hundred twenty-five patients were treated prospectively for 48 wk with TPV or BOC + pegylated-interferon(peg-INF) α2a + ribavirin(PR) according to standard treatment schedules without randomization.These patients were treated in routine practice settings in 10 public or private health care centers,and the data were prospectively collected.Only patients with severe liver fibrosis(Metavir scores of F3 or F4 upon liver biopsy or liver stiffness assessed by elastography),genotype 1 HCV and who were null-responders or relapsers to prior PR combination therapy were included in this study.RESULTS:The Metavir fibrosis scores were F3 in 35(28%) and F4 in 90(72%) of the patients.In total,62.9% of the patients were null-responders and 37.1% relapsers to the previous PR therapy.The overall SVR rate at 24 wk post-treatment withdrawal was 59.8%.The SVR was 65.9% in the TPV group and 44.1% in the BOC group.Independent predictive factors of an SVR included a response to previous treatment,relapsers vs null-responders [OR = 3.9;(1.4,10.6),P = 0.0084],a rapid virological response(RVR) [OR 6.9(2.6,18.2),P = 0.001] and liver stiffness lower than 21.3 kPa [OR = 8.2(2.3,29.5),P = 0.001].During treatment,63 patients(50.8%) had at least one severe adverse event(SAE) of grade 3 or 4.A multivariate analysis identified two factors associated with SAEs:female gender [OR = 2.4(1.1,5.6),P = 0.037] and a platelet count below 150 × 103/ mm3 [OR = 5.3(2.3,12.4),P ≤ 0.001].CONCLUSION:More than half of these difficult-to-treat patients achieved an SVR and had SAEs in an actual practice setting.The SVR rate was influenced by the response to previous PR treatment,the RVR and liver stiffness. | Delphine Bonnet Matthieu Guivarch Anais Palacin Laurent Alric Emilie Bérard Jean-Marc Combis Andre Jean Remy Andre Glibert Jean-Louis Payen Sophie Metivier Karl Barange Herve Desmorat Florence Nicot Florence Abravanel | 2014 | World Journal of Hepatology2014，6，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员